REGENXBIO, Inc. (RGNX)
8.64
-0.08
(-0.92%)
USD |
NASDAQ |
Mar 06, 16:00
8.64
0.00 (0.00%)
After-Hours: 16:49
REGENXBIO Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 96.21M |
| BioMarin Pharmaceutical, Inc. | -42.45M |
| Omeros Corp. | -6.861M |
| Ultragenyx Pharmaceutical, Inc. | -72.25M |
| CytomX Therapeutics, Inc. | 0.439M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -106.28M |
| Free Cash Flow Per Share (Quarterly) | -1.092 |
| Free Cash Flow to Equity (Quarterly) | -52.90M |
| Free Cash Flow to Firm (Quarterly) | -43.28M |
| Free Cash Flow Yield | -23.84% |